AAPS 2026 PharmSci 360

PharmSci 360 connects experimental, computational and clinical evidence across drug discovery, development and delivery. Researchers will examine in-vitro-to-human translation using PBPK, quantitative systems pharmacology and AI; organ-chip and other human-relevant models; biomarkers and reliable bioanalytical assays; and integrating clinical trials with real-world data. Manufacturing sessions connect process understanding, analytical characterization and digital models with quality and scale-up. Formulation sessions address predictive design, advanced materials, targeted delivery and patient usability, alongside career development. Programme participants include Julie L. Gerberding (Foundation for the National Institutes of Health (FNIH)); Stephanie Barrett (Merck & Co., Inc.); Ben Boyd (Monash Institute of Pharmaceutical Sciences); Stephan Schmidt (University of Florida); Douglas Kiehl (Purdue University); Samir Mitragotri (Harvard University); Eric Appel (Stanford University).

The American Association of Pharmaceutical Scientists hosts this in-person meeting at the Ernest N. Morial Convention Center, New Orleans, on 25–28 October 2026. The opening plenary is 25 October, 17:00–18:30; principal scientific symposia start at 09:00 on 26–28 October. The closing plenary is 28 October, 16:15–17:30, followed by a reception until 18:30. Times are America/Chicago, CDT (UTC−05:00). Current full-conference fees are US$1,705 for members, US$2,145 for non-members and US$325 for student/postdoc members; one-day passes are available. Registration requires an AAPS portal account. Use the official registration page linked from the event website. Ordinary cancellation refunds are no longer available.